Multi-Parameter MR Radiomics Based Model to Predict 5-Year Progression-Free Survival in Endometrial Cancer
Authors:
Open Access
- 31 March 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 813069
Abstract
Background: Relapse is the major cause of mortality in patients with resected endometrial cancer (EC). There is an urgent need for a feasible method to identify patients with high risk of relapse.Purpose: To develop a multi-parameter magnetic resonance imaging (MRI) radiomics-based nomogram model to predict 5-year progression-free survival (PFS) in EC.Methods: For this retrospective study, 202 patients with EC followed up for at least 5 years after hysterectomy. A radiomics signature was extracted from T2-weighted imaging (T2WI), apparent diffusion coefficient (ADC) and a dynamic contrast-enhanced three-dimensional volumetric interpolated breath-hold examination (3D-VIBE). The radiomics score (RS) was calculated based on the least absolute shrinkage and selection operator (LASSO) regression. We have developed a radiomics based nomogram model (ModelN) incorporating the RS and clinical and conventional MR (cMR) risk factors. The performance was evaluated by the receiver operating characteristic curve (ROC), calibration curve and decision curve analysis (DCA).Results: The ModelN demonstrated a good calibration and satisfactory discrimination, with a mean area under the curve (AUC) of 0.840 and 0.958 in the training and test cohorts, respectively. In comparison with clinical prediction model (ModelC), the discrimination ability of ModelN showed an improvement with P < 0.001 for the training cohort and P=0.032 for the test cohort. Compared to the radiomics prediction model (ModelR), ModelN discrimination ability showed an improvement for the training cohort with P = 0.021, with no statistically significant difference in the test cohort (P = 0.106). Calibration curves suggested a good fit for probability (Hosmer–Lemeshow test, P = 0.610 and P = 0.956 for the training and test cohorts, respectively).Conclusion: This multi-parameter nomogram model incorporating clinical and cMR findings is a valid method to predict 5-year PFS in patients with EC.Keywords
Funding Information
- National Natural Science Foundation of China (81871029)
This publication has 41 references indexed in Scilit:
- Endometrial cancer: diagnostic value of quantitative measurements of microvascular changes with DCE-MR imagingMagnetic Resonance Materials in Physics, Biology and Medicine, 2014
- FIGO staging for carcinoma of the vulva, cervix, and corpus uteriInternational Journal of Gynecology & Obstetrics, 2014
- Non–Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CTRadiology, 2013
- Texture analysis in assessment and prediction of chemotherapy response in breast cancerJournal of Magnetic Resonance Imaging, 2012
- Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric CancerJournal of Clinical Oncology, 2012
- Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stageBMC Cancer, 2012
- Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancerGynecologic Oncology, 2012
- Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcomeGynecologic Oncology, 2011
- Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)Endocrine-Related Cancer, 2008
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004